NEW DELHI: Serum Institute of India (SII), the world’s biggest vaccine maker by volume, on Sunday (Feb 21) asked for patience from foreign governments awaiting their supply of COVID-19 shots, saying it had been directed to prioritise India’s requirements.
“… I humbly request you to please be patient,” SII’s Chief Executive Adar Poonawalla said in a tweet, adding the company “has been directed to prioritise the huge needs of India and along with that balance the needs of the rest of the world”.
Advertisement
Advertisement
“We are trying our best,” Poonawalla said.
Based in the western Indian city of Pune, the company is manufacturing the Oxford University and AstraZeneca COVID-19 vaccine, one of the two shots that India is using to initially vaccinate about 300 million people as part of a national inoculation drive.
READ: India to multiply COVID-19 vaccinations amid coverage concerns
READ: India, pharmacy of the world, falls behind on COVID-19 vaccinations at home
Advertisement
Advertisement
Many low-and middle-income countries, ranging from Bangladesh to Brazil, are depending on SII’s AstraZeneca vaccine, branded COVISHIELD by the Indian company.
But demand is growing, including from Western countries like Canada, where Poonawalla has promised to deliver the COVISHIELD vaccine next month.
Britain’s drug regulator is also auditing manufacturing processes at SII, potentially paving the way for the COVISHIELD vaccine to be shipped from there to the UK and other countries..
Indian Prime Minister Narendra Modi’s government has come under criticism for the slow take-off of its vaccination drive but health authorities are preparing to expand the number of inoculation substantially in coming weeks.
Advertisement
India has vaccinated around 11 million people since mid-January.
With more than 10.9 million confirmed infections, India has the world’s second highest number of COVID-19 cases, behind only the United States.
READ: India COVID-19 infections at 3-week high, Mumbai hires marshals to enforce mask-wearing
The country is currently reporting around 12,000 new infections on average each day, a fraction of its peak from last September, according to a Reuters analysis.
But federal health authorities on Sunday said they had written to some states that are currently seeing a surge in cases, asking them to improve overall testing, surveillance and monitoring of COVID-19 mutations.
BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments
Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram
Gzqtbh says
clozaril 50mg us – buy aceon generic order famotidine 20mg pill
Dlgxnq says
glucophage 1000mg sale – epivir over the counter lincocin 500mg pill
Znjiwr says
ciplox 500mg canada – cheap generic chloromycetin erythromycin 250mg oral
Bagxek says
proscar 1mg pills propecia 1mg without prescription order fluconazole generic
Gneuzt says
zocor for sale online order zocor 10mg sale valacyclovir for sale
Eruste says
buy zofran 4mg online purchase aldactone online cheap buy spironolactone sale
Rargcb says
order tamsulosin 0.2mg generic flomax cheap buy celebrex generic
Jwyffc says
speechwriters buy my essay editing essays
Bzesim says
order medrol for sale how to get methylprednisolone without a prescription medrol 4mg pills
Rcgain says
order atenolol 100mg generic buy tenormin medication atenolol 100mg over the counter
Zzodzc says
order metoprolol online metoprolol 50mg generic metoprolol us